Urological reconstruction after pelvic oncological surgery: A single institution experience

医学 普通外科 外科
作者
Yu Guang Tan,Grace Hwei Ching Tan,David S.P. Tan,Claramae Shulyn Chia,Dun Yong Ang,Melissa Ching Ching Teo
出处
期刊:Asian Journal of Surgery [Elsevier BV]
卷期号:40 (5): 389-395 被引量:7
标识
DOI:10.1016/j.asjsur.2016.02.002
摘要

In locally advanced pelvic malignancies, there is often involvement of urological organs, necessitating resection and reconstruction, which can be associated with significant complications.We retrospectively reviewed 20 patients undergoing urological reconstructions during pelvic oncological surgeries from January 2004 to December 2013. All patients had imaging-proven involvement of at least one urological organ preoperatively. Primary outcome was urological complication rate. Secondary outcomes were nonurological complication, recurrence rate, and overall survival.Median age of presentation was 51 years. Six and 14 patients underwent resections for primary and secondary tumors, respectively. Colorectal tumors were the most common, followed by gynecological cancers. The ureter was the most common urological organ involved, followed by the bladder, prostate, and seminal vesicles. Reconstructive procedures included ileal and sigmoid conduits, ureteroneocystostomies, Boari flap, transureteroureterostomies (TUUs) and direct ureteroureterostomies. Six patients developed major urological complications, requiring endoscopic and surgical reinterventions. The follow-up time was 34 months. Thirteen patients developed recurrence, associated with higher tumor grade and lymphovascular invasion, and occurred at a median time of 10 months. These patients had an overall survival of 20 months, compared to 45 months in patients without recurrence.Careful patient selection in pelvic oncological surgeries can significantly prolong survival. Recurrent tumors and greater intraoperative blood loss are associated with higher urological complications. A limited pelvic exenteration and lower radiation doses can reduce complication rates. If higher doses are necessary, conformal techniques and hyperfractionated radiotherapy should be explored. Urological reconstruction should be individualized, according to the extensiveness of urological involvement and exposure of radiation.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
莫问发布了新的文献求助10
刚刚
刚刚
东方元语完成签到,获得积分0
刚刚
zhouyelly发布了新的文献求助10
2秒前
夏柒完成签到 ,获得积分10
3秒前
江涸完成签到,获得积分10
3秒前
Luo完成签到 ,获得积分10
4秒前
负责雨安完成签到 ,获得积分10
4秒前
LiuZheng发布了新的文献求助10
4秒前
Linz完成签到 ,获得积分10
5秒前
蓝海完成签到,获得积分10
5秒前
潘健康发布了新的文献求助10
5秒前
6秒前
欢呼的白玉完成签到 ,获得积分10
9秒前
Yanzhi完成签到,获得积分10
9秒前
Akim应助xqx采纳,获得10
10秒前
ding应助passby采纳,获得10
11秒前
xiliyusheng发布了新的文献求助10
11秒前
总爱小迷糊完成签到,获得积分10
12秒前
tanx完成签到,获得积分10
12秒前
12秒前
Snail6完成签到,获得积分10
13秒前
LiuZheng完成签到,获得积分20
14秒前
22336完成签到,获得积分0
14秒前
江沉晚吟时完成签到,获得积分10
14秒前
姜菲菲完成签到,获得积分10
15秒前
sunwsmile完成签到 ,获得积分10
16秒前
微笑的水桃完成签到 ,获得积分0
16秒前
Korai完成签到 ,获得积分10
16秒前
草莓瑶瑶乐完成签到 ,获得积分10
17秒前
18秒前
草珊瑚发布了新的文献求助10
18秒前
19秒前
顾君如完成签到,获得积分10
20秒前
cl完成签到,获得积分10
20秒前
顺心成仁完成签到 ,获得积分10
21秒前
无极微光完成签到,获得积分0
21秒前
Sophia完成签到 ,获得积分10
21秒前
Deiog完成签到 ,获得积分10
22秒前
修仙中应助江沉晚吟时采纳,获得10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
CLSI VET01S-2024 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals (7th Ed) 500
DIPPR Project 801 - Full Version 380
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7765974
求助须知:如何正确求助?哪些是违规求助? 9309928
关于积分的说明 20313210
捐赠科研通 7350762
什么是DOI,文献DOI怎么找? 3315010
关于科研通互助平台的介绍 2464543
邀请新用户注册赠送积分活动 2329584